US Bancorp
EXAS

US Bancorp’s Exact Sciences EXAS Stock Holding History

US Bancorp’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-146,171
Closed -$14.8M – 4217
2025
Q4 		$14.8M Sell
146,171
-23,049
-14% -$1.85M 0.02% 364
2025
Q3 		$9.26M Sell
169,220
-38,148
-18% -$1.91M 0.01% 448
2025
Q2 		$11M Sell
207,368
-201,649
-49% -$10.2M 0.01% 409
2025
Q1 		$17.7M Buy
409,017
+273,602
+202% +$13.9M 0.02% 332
2024
Q4 		$7.61M Sell
135,415
-9,278
-6% -$577K 0.01% 480
2024
Q3 		$9.86M Sell
144,693
-10,749
-7% -$607K 0.01% 435
2024
Q2 		$6.57M Sell
155,442
-18,070
-10% -$994K 0.01% 513
2024
Q1 		$12M Sell
173,512
-30,727
-15% -$1.94M 0.02% 392
2023
Q4 		$15.1M Sell
204,239
-22,357
-10% -$1.47M 0.02% 350
2023
Q3 		$15.5M Sell
226,596
-31,383
-12% -$2.66M 0.03% 330
2023
Q2 		$24.2M Sell
257,979
-176,211
-41% -$13.7M 0.04% 266
2023
Q1 		$29.4M Sell
434,190
-55,233
-11% -$3.55M 0.05% 236
2022
Q4 		$24.2M Buy
489,423
+122,490
+33% +$5M 0.04% 259
2022
Q3 		$11.9M Sell
366,933
-33,254
-8% -$1.37M 0.02% 340
2022
Q2 		$15.8M Sell
400,187
-79,457
-17% -$4.25M 0.03% 307
2022
Q1 		$33.5M Sell
479,644
-59,799
-11% -$4.37M 0.06% 209
2021
Q4 		$42M Buy
539,443
+133,724
+33% +$11.8M 0.07% 199
2021
Q3 		$38.7M Buy
405,719
+274,904
+210% +$29M 0.07% 197
2021
Q2 		$16.3M Buy
130,815
+12,268
+10% +$1.46M 0.03% 327
2021
Q1 		$15.6M Buy
118,547
+19,761
+20% +$2.7M 0.03% 319
2020
Q4 		$13.1M Buy
98,786
+9,312
+10% +$1.13M 0.03% 342
2020
Q3 		$9.12M Buy
89,474
+39,204
+78% +$3.39M 0.02% 373
2020
Q2 		$4.37M Buy
50,270
+9,313
+23% +$744K 0.01% 515
2020
Q1 		$2.38M Sell
40,957
-39,332
-49% -$3.19M 0.01% 615
2019
Q4 		$7.43M Sell
80,289
-22,731
-22% -$2M 0.02% 414
2019
Q3 		$9.31M Buy
103,020
+91
+0.1% +$10.4K 0.03% 368
2019
Q2 		$12.2M Sell
102,929
-6,723
-6% -$677K 0.03% 332
2019
Q1 		$9.5M Buy
109,652
+486
+0.4% +$41.4K 0.03% 363
2018
Q4 		$6.89M Sell
109,166
-2,102
-2% -$144K 0.02% 398
2018
Q3 		$8.78M Sell
111,268
-1,152
-1% -$75.1K 0.03% 391
2018
Q2 		$6.72M Sell
112,420
-613,475
-85% -$33M 0.02% 420
2018
Q1 		$29.3M Sell
725,895
-1,044
-0.1% -$50.9K 0.09% 185
2017
Q4 		$38.2M Sell
726,939
-3,730
-0.5% -$199K 0.12% 161
2017
Q3 		$34.4M Buy
730,669
+479,736
+191% +$19.3M 0.11% 161
2017
Q2 		$8.88M Sell
250,933
-1,939
-0.8% -$59.9K 0.03% 363
2017
Q1 		$5.97M Sell
252,872
-106
-0% -$2.1K 0.02% 447
2016
Q4 		$3.38M Buy
252,978
+7,089
+3% +$114K 0.01% 582
2016
Q3 		$4.57M Sell
245,889
-2,933
-1% -$51.7K 0.02% 481
2016
Q2 		$3.05M Buy
248,822
+9,265
+4% +$69.8K 0.01% 573
2016
Q1 		$1.61M Buy
239,557
+9,963
+4% +$63.7K 0.01% 771
2015
Q4 		$2.12M Buy
229,594
+5,109
+2% +$47.5K 0.01% 684
2015
Q3 		$4.04M Sell
224,485
-1,887
-0.8% -$43.3K 0.02% 495
2015
Q2 		$6.73M Buy
226,372
+4,960
+2% +$125K 0.03% 406
2015
Q1 		$4.88M Buy
221,412
+6,131
+3% +$156K 0.02% 464
2014
Q4 		$5.91M Buy
215,281
+81,830
+61% +$1.99M 0.02% 413
2014
Q3 		$2.59M Buy
133,451
+126,246
+1,752% +$2.31M 0.01% 601
2014
Q2 		$123K Sell
7,205
-13,775
-66% -$190K ﹤0.01% 2025
2014
Q1 		$298K Sell
20,980
-18,065
-46% -$244K ﹤0.01% 1567
2013
Q4 		$459K Buy
39,045
+11,670
+43% +$134K ﹤0.01% 1338
2013
Q3 		$323K Hold
27,375
– – ﹤0.01% 1449
2013
Q2 		$381K Buy
+27,375
New +$297K ﹤0.01% 1310

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

US Bancorp's EXAS Position: Q1 2026 in Review

US Bancorp sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 146,171 shares — an estimated $14.8M sold.

US Bancorp first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $42M in Q4 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • US Bancorp reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • US Bancorp sold 146,171 Exact Sciences shares in Q1 2026, an estimated $14.8M.
  • US Bancorp first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
  • US Bancorp's Exact Sciences position peaked at $42M in Q4 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.